Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis
Authors:
Top Cited Papers
- 25 December 2020
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 253 (4) , 355-365
Abstract
Endometrial carcinoma (EC) is classified into a wide range of morphological variants; this list has expanded over the past decade with the inclusion of mesonephric‐like and dedifferentiated carcinoma as EC variants in the fifth edition of the WHO Classification of Female Genital Tumours, and recognition that carcinosarcoma is a biphasic carcinoma rather than a sarcoma. Each EC variant has distinct molecular abnormalities, including TCGA‐based molecular subtypes, allowing further subclassification and adding complexity. In contrast to this rapid progress in understanding EC, there are only two recognized EC precursor lesions: endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia (EAH/EIN) and serous intraepithelial carcinoma, a situation that has not changed for many years. Diagnosis of EC precursors is a cornerstone of surgical pathology practice, with early diagnosis contributing to the relatively favorable prognosis of EC. In this review we relate the precursor lesions to each of the EC morphological variants and molecular subtypes, discuss how successful early diagnosis is for each variant/molecular subtype and how it might be improved, and identify knowledge gaps where there is insufficient understanding of EC histogenesis. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 89 references indexed in Scilit:
- Serous endometrial intraepithelial carcinoma: a case series and literature reviewCancer Management and Research, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancerHuman Molecular Genetics, 2013
- A Proposed Model for Endometrial Serous CarcinogenesisAmerican Journal of Surgical Pathology, 2011
- Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical–pathological and immunohistochemical studyVirchows Archiv, 2010
- Molecular Identification of “Latent Precancers” for Endometrial Serous Carcinoma in Benign-Appearing EndometriumThe American Journal of Pathology, 2009
- Pathologic features of endometrial carcinoma associated with HNPCCCancer, 2005
- The 3′–5′ exonucleasesNature Reviews Molecular Cell Biology, 2002
- Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative reviewBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Minimal Uterine Serous CarcinomaAmerican Journal of Surgical Pathology, 2000